ASX - By Stock
|
MSB |
Re:
The MSB pattern
|
|
yelrom
|
184 |
1.1M |
7 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
184
|
1.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
The MSB pattern
|
|
yelrom
|
184 |
1.1M |
15 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
184
|
1.1M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
15 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
16 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
422
|
145K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
26 |
11/04/21 |
11/04/21 |
ASX - By Stock
|
422
|
145K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
39 |
11/04/21 |
11/04/21 |
ASX - By Stock
|
422
|
145K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
MESO trading tonight
|
|
yelrom
|
136 |
55K |
17 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
136
|
55K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Ltd Files For Shelf Of Up To $180 Mln ADS Representing Ordinary Shares
|
|
yelrom
|
110 |
37K |
10 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
110
|
37K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MESO trading tonight
|
|
yelrom
|
136 |
55K |
2 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
136
|
55K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Ltd Files For Shelf Of Up To $180 Mln ADS Representing Ordinary Shares
|
|
yelrom
|
110 |
37K |
23 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
110
|
37K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
6 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Ltd Files For Shelf Of Up To $180 Mln ADS Representing Ordinary Shares
|
|
yelrom
|
110 |
37K |
13 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
110
|
37K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
yelrom
|
429 |
130K |
13 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
429
|
130K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
yelrom
|
429 |
130K |
3 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
429
|
130K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Operational Highlights and Upcoming Milestones
|
|
yelrom
|
177 |
57K |
0 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
177
|
57K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
5 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
9 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
2 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
4 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Operational Highlights and Upcoming Milestones
|
|
yelrom
|
177 |
57K |
19 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
177
|
57K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment/Resignation
|
|
yelrom
|
141 |
43K |
17 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
141
|
43K
|
17
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
20 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment/Resignation
|
|
yelrom
|
141 |
43K |
18 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
141
|
43K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
yelrom
|
429 |
130K |
20 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
429
|
130K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
10 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
10K |
3.0M |
1 |
27/03/21 |
27/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
10K |
3.0M |
2 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
10K |
3.0M |
4 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
yelrom
|
429 |
130K |
5 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
429
|
130K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
10K |
3.0M |
7 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
10K |
3.0M |
7 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
5 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
24 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
422
|
145K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
It really should not be this borning
|
|
yelrom
|
61 |
10K |
43 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
61
|
10K
|
43
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
13 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
15 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
21 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
7 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
yelrom
|
518 |
147K |
24 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
518
|
147K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
10K |
3.0M |
8 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
1 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
6 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Questions for MSB Management:
|
|
yelrom
|
106 |
28K |
20 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
106
|
28K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
2 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
905
|
286K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
2 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
905
|
286K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
6 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
905
|
286K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
10 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
2 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
905
|
286K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
1 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
905
|
286K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
16 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
905
|
286K
|
16
|
|